Pulmotil AC 250 mg/mL concentrate for oral solution for use in drinking water or milk replacer for chickens, turkeys, pigs and calves
Pulmotil AC 250 mg/mL concentrate for oral solution for use in drinking water or milk replacer for chickens, turkeys, pigs and calves
Authorised
- Tilmicosin
Product identification
Medicine name:
Pulmotil AC 250 mg/mL concentrate for oral solution for use in drinking water or milk replacer for chickens, turkeys, pigs and calves
Active substance:
- Tilmicosin
Target species:
-
Chicken
-
Turkey
-
Pig
-
Cattle (pre-ruminant)
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Tilmicosin250.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Concentrate for oral solution
Withdrawal period by route of administration:
-
Oral use
-
Chicken
-
Meat and offal12dayNot authorised for use in laying birds producing eggs for human consumption. Do not use within 14 days of the start of the laying period
-
-
Turkey
-
Meat and offal19dayNot authorised for use in laying birds producing eggs for human consumption. Do not use within 14 days of the start of the laying period
-
-
Pig
-
Meat and offal14day
-
-
Cattle (pre-ruminant)
-
Meat and offal42dayNot authorised for use in animals producing milk for human consumption.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FA91
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- Polyethylene naphthalate amber coloured bottle containing 240 mL of veterinary medicinal product, with a polypropylene screw top and polyethylene/aluminium/polyethylene terephthalate seal.
- Polyethylene naphthalate amber coloured bottle containing 960 mL of veterinary medicinal product, with a polypropylene screw top and polyethylene/aluminium/polyethylene terephthalate seal.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Elanco France S.A.S.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V206613
Date of authorisation status change:
Reference member state:
-
Italy
Procedure number:
- IT/V/0102/001
Concerned member states:
-
Belgium
-
Greece
-
Luxembourg
-
Netherlands
-
Portugal
-
Spain
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 18/02/2024
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Labelling
This document does not exist in this language (English). You can find it in another language below.
